Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Smith

Orthopaedic Surgery Tifton, GA Medical Doctor

NPI 1730269473 CMS profile 498175

2227 US Highway 41 N, Tifton, GA 31794

Open in the dashboard

General payments

$650

25 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, William Smith of Tifton, GA is reported in the CMS Open Payments database as having received $650 across 25 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 25th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $191 3
2024 General $33 1
2023 General $26 1
2021 General $14 1
2020 General $92 4
2019 General $294 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Smith
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to William Smith were reported at $191. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year William Smith Orthopaedic Surgery median Middle half National median
2019 $294 $644 $140–$2,844 $163
2020 $92 $312 $75–$1,860 $114
2021 $14 $520 $117–$2,495 $132
2022 $0 $598 $128–$2,731 $149
2023 $26 $461 $128–$2,264 $160
2024 $33 $497 $134–$2,475 $164
2025 $191 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Curiteva, Inc. $148 1 payment
  2. Flexion Therapeutics, Inc. $140 9 payments
  3. Zimmer Biomet Holdings, Inc. $108 4 payments
  4. Smith+Nephew, Inc. $76 2 payments
  5. DePuy Synthes Sales Inc. $56 2 payments
  6. OrthoGrid Systems Inc $39 2 payments
  7. Ferring Pharmaceuticals Inc. $36 3 payments
  8. Pacira Pharmaceuticals Incorporated $26 1 payment
  9. Vertex Pharmaceuticals Incorporated $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $650 25 payments
Products named General payments · program years 2019–2025
  1. Zilretta musculoskeletal $140 9 payments
  2. Regeneten $76 2 payments
  3. MONOVISC $56 2 payments
  4. ROSA-Knee $37 1 payment
  5. EUFLEXXA $36 3 payments
  6. Iovera $26 1 payment
  7. Exparel $26 1 payment
  8. Zilretta Pain Management $26 1 payment
  9. Persona $21 1 payment
  10. JOURNAVX $21 1 payment
  11. Other $15 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

460

Median for Orthopedic Surgery: 203

Drug cost

$3,761

Median for Orthopedic Surgery: $1,433

Branded share of claims

26.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 170 $1,114
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 110 $722
Diclofenac Sodium Generic 11 $705
Cephalexin Generic 15 $374
Celecoxib Generic 18 $328
Tramadol Hcl Generic 60 $242
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 13 $97
Ondansetron Hcl Generic 12 $73
Meloxicam Generic 22 $51
Levofloxacin Generic 17 $44

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 83 billing codes

Paid by Medicare

$334,284

Of which drugs: $172,759

Medicare patients

486

Average age 75

Services billed

28,675

300 women, 186 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 33%
Ischemic heart disease 27%
Chronic kidney disease 22%
Depression 19%
Osteoporosis 18%
Atrial fibrillation 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg J3304 Office 142 12,450 $168,676
Injection, methylprednisolone acetate, 1 mg J1010 Office 183 13,600 $1,337
Injection, methylprednisolone acetate, 40 mg J1030 Office 50 81 $291
Injection, ketorolac tromethamine, per 15 mg J1885 Office 11 44 $18

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

25 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record